Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07535749 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Effect of Myopia-Control Contact Lenses in New Zealand Chinese Children

StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Nov 30, 2026 → Apr 30, 2027
See other at-risk trials from Aston University

Record History

  1. Enrollment closed, study ongoingv2 Show 4 more changesShow less
    • Primary completion pushed from Nov 30, 2026 to Apr 30, 2027
    • Study completion pushed from Dec 30, 2026 to May 30, 2027
    • Secondary endpoints: details revised at 5 of 5 entries
    • Site details revised
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study will employ a randomized, controlled, investigator-masked paired-eye comparison design to evaluate the effects of two myopia-control contact lenses-MiSight 1 Day and Abiliti 1-Day-in New Zealand Chinese children. The study duration will be 12 months, with assessments conducted at baseline, 2 weeks, 3 months, 6 months and 12 months. The clinical research will be conducted at the Auckland Myopia Clinic (New Zealand) and will follow a standard clinical routine for children with early myopia, the only difference being the randomizing of the MiSight and Abiliti contact lenses between the two eyes of the participants.
Trial Details
NCT Number NCT07535749
Lead Sponsor Aston University
Conditions
(from sponsor)		 Myopia Progression
Enrollment 66 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov